David Young

CIK 1378166 · Pres. Research & Development · last filed 2026-06-01

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$38.1K

Companies

3

Total Filings

63

Lifetime Open-Market Net

-$14.49M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PCSA Pres. Research & Development 17,563 $2.17 $38.1K $373.0K 37 2026-06-01
QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted Chief Scientific Officer 122,366 -$14.87M 21 2014-03-18
QUESTCOR PHARMACEUTICALS INC (QSC) Delisted Director $0 4 2008-01-03

Recent Filings · Page 2 of 7

63 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-02-18 PCSA Grant (A) $0 EDGAR
2025-01-29 PCSA Buy (P) +124,500 $99.3K EDGAR
2024-08-02 PCSA Mixed +1,519 -$1.9K EDGAR
2024-04-12 PCSA Mixed +1,157 -$1.4K EDGAR
2024-02-08 PCSA Buy (P) +21,000 $51.5K EDGAR
2024-02-07 PCSA Buy (P) +20,000 $50.5K EDGAR
2023-10-12 PCSA Grant (A) +155,277 $45.0K EDGAR
2023-10-10 PCSA Grant (A) +142,000 $34.1K EDGAR
2023-06-12 PCSA Buy (P) +40,000 $32.0K EDGAR
2023-04-14 PCSA Buy (P) +20,000 $11.0K EDGAR
Showing 1120 of 63
Page 2 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.